by v.tondi@deanvial.com | Dec 19, 2021 | Geen categorie
Market Access We believe Access Matters to everybody. Through our solutions we help you lay the foundation for new technologies and construct new indicators to assess the impact on healthcare. Learn More Igniting Access To Innovative Therapies Our market access...
by v.tondi@deanvial.com | Nov 30, 2021 | Geen categorie
We’re looking forward to meeting you Please feel free to contact us. We’re always glad to offer you our support, discuss how to generate new evidences and disseminate results of modern-day advances in medical science. We will be glad to listen to you, and we...
by v.tondi@deanvial.com | Oct 7, 2021 | Geen categorie
Isheo Research Bulletin 1.2021 on Rare DiseaseThe unmet need of patients with Epidermolysis Bullosa Get the RIGHT ACCESS The access of patients with rare diseases matters, it is not just a slogan but a way to remember that patients with rare diseases often find it...
by v.tondi@deanvial.com | Sep 30, 2021 | Geen categorie
Evidence Synthesis in the EU In this webinar, ISHEO and AREX Advisor focused on presenting an overview of how different EU countries apply Evidence Synthesis to provide a compass and help professionals navigate the sea of uncertainty created by the vast set of...
by v.tondi@deanvial.com | Sep 30, 2021 | Geen categorie
What are Patient Reported Outcomes During the last webinar, ‘Patient-Reported Outcomes’ organized by ISHEO into its Access matters webinar series, Davide Integlia, CEO of ISHEO, interviews Linda Abet Webb, CEO of P-COA, focusing on how Patient-Reported...
by v.tondi@deanvial.com | Sep 24, 2021 | Geen categorie
Market Access in Italy What does “Access” mean? Nowadays, the concept of “access” is comprehensive and needs to be declined in its multiple meanings. In particular, we can consider three different definitions of “access”. Access to...
